ANKMJ
Ankyra Medical Journal

Ankyra Medical Journal (AnkMJ), formerly known as the Journal of Translational and Practical Medicine, regularly publishes international quality issues in the field of Medicine in the light of current information.

eISSN: 3023-655X
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
A case developing Candida auris related candidaemia following multiple drug-resistant Klebsiella pneumoniae meningitis after neurosurgical intervention
Abstract
A 28-year-old man who underwent ventriculoperitoneal shunt (VPS) operation at another medical center due to epidural abscess and hydrocephalus was admitted due to deterioration of his general condition. WBC count was 9360/mm³, C-reactive protein (CRP) was 54 mg/L (normal range <5 mg/L) and glomerular filtration rate was 150 ml/min, while the results of other laboratory tests were nonspecific. He was receiving vancomycin and meropenem treatment. Urine cultures were taken during hospitalization and again 48 hours later and Candida auris (C. auris) growth of 105 cfu/ml was detected. On the 4th day of hospitalization, the patient was intubated due to decreased oxygen saturation, and while under meropenem and vancomycin treatment, carbapenem-resistant, gentamicin and ceftazidime-avibactam-susceptible and multidrug-resistant Klebsiella pneumoniae growth was detected in CSF culture. The patient's ventriculoperitoneal shunt was removed and hydrocephalus was followed with extra-ventricular drainage (EVD). Vancomycin treatment was discontinued and intrathecal (IT) gentamicin treatment was started. Due to the susceptibility of Klebsiella pneumoniae growth from deep tracheal aspirate to ceftazidime-avibactam, antibiotic treatment was changed to intravenous (IV) meropenem, IV ceftazidime-avibactam and IT gentamicin and treatment was continued for 10 days. No growth was detected in CSF culture obtained under treatment. On the 20th day of hospitalization due to deterioration of his clinical condition under treatment, tracheostomy was performed, he was intubated, blood and urine cultures were repeated and C. auris growth was detected in blood culture on the 27th day after hospitalization using VITEK MS MALDITOF (bioMérieux, France) microbiological identification system. Confirmation of the C. auris species and antifungal susceptibility testing was performed by the Mycology Reference Laboratory, Institute of Public Health and antibiotic treatment was stopped. According to the antifungal susceptibility test results, the patient was started on anidulafungin. In conclusion, nosocomial C. auris infection should be considered in patients with underlying predisposing factors such as long intensive care unit stays, broad-spectrum antibiotic use, surgical interventions, central venous catheter use, intubation and infection due to gram-negative bacteria.

Keywords : Nosocomial meningitis, multidrug-resistant Klebsiella pneumoniae, Candida auris, candidemia

Download Article


1. Iaria C, Giammalva GR, Spicola D, et al. Multidrug-resistant gram-negative post-neurosurgical meningitis and the role of intraventricular colistin: a case series. Infez Med. 2021;29(1):130-137.
2. Patrial YC, Tortorelli LP, Rodrigues ACS, et al. Post-neurosurgical meningitis caused by KPC-producing Klebsiella pneumoniae: report of two cases. Rev Inst Med Trop Sao Paulo. 2019;61:e69. doi:10.1590/S1678-9946201961069
3. Osei Sekyere J. Candida auris: a systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiologyopen. 2018;7(4):e00578. doi:10.1002/mbo3.578
4. B&ouml;l&uuml;kbaşı Y, Orhun G, Kuşkucu MA, et al. First case of COVID-19 positive Candida auris fungemia in Turkey. Mikrobiyol Bul. 2021;55(4): 648-655. doi:10.5578/mb.20219716
5. Thoma R, Seneghini M, Seiffert SN, et al. The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature. Antimicrob Resist Infect Control. 2022;11(1):12. doi:10.1186/s13756-022-01052-8
6. K&ouml;me&ccedil; S, Karabı&ccedil;ak N, Ceylan AN, G&uuml;lmez A, &Ouml;zalp O. T&uuml;rkiye İstanbul&rsquo;dan bildirilen &uuml;&ccedil; Candida auris olgusu. Mikrobiyol Bul. 2021; 55(3):452-460. doi:10.5578/mb.20219814
7. Karabı&ccedil;ak N, Tek&ccedil;e Yz, K&ouml;me&ccedil; S, Y&uuml;cel M, Bozkurt ENN. T&uuml;rkiye&rsquo;deki &ccedil;eşitli hastanelerden flukonazol diren&ccedil;li Candida auris izolatlarının dizi analizleri ile ileri identifikasyonu ve antifungal duyarlılık profilleri. 6. Ulusal Klinik Mikrobiyoloji Hibrid Kongresi, 20-24 Ekim 2021.
8. Kulaklı K, Arslan N, G&uuml;rsan O, &Ouml;zk&uuml;t&uuml;k AA. İzmir&rsquo;den ilk Candida auris olgusu: amputasyon ile sonu&ccedil;lanan diyabetikayak enfeksiyomu. 6. Ulusal Klinik Mikrobiyoloji Hibrid Kongresi, 20-24 Ekim 2021.
9. Aslan M, Turan D, Altunal LN, Aksaray S. Laboratuarımızda izole edilen ilk C. auris olgusu. 6. Ulusal Klinik Mikrobiyoloji Hibrid Kongresi, 20-24 Ekim 2021.
10. &Ouml;ncel B, Ceylan AN. Yoğun bakım &uuml;nitesindeki tehdit; invazif maya enfeksiyonları ve &ccedil;oklu ilaca diren&ccedil;li Candida auris. 6. Ulusal Klinik Mikrobiyoloji Hibrid Kongresi, 20-24 Ekim 2021.
11. Sreejith P, Vishad V, Pappachan JM, Laly DC, Jayaprakash R, Ranjith VT. Pneumocephalus as a complication of multidrug-resistant Klebsiella pneumoniae meningitis. Eur J Intern Med. 2008;19(2):140-142. doi:10.1016/j.ejim.2007.03.021
12. Garc&iacute;a CS, Palop NT, Bayona JVM, et al. Candida auris: report of an outbreak. Enferm Infecc Microbiol Clin (Engl Ed). 2020;38(Suppl 1):39-44. doi:10.1016/j.eimc.2020.02.007
13. Alp Ş, Akdağlı SA. Candida auris ve antifungal ila&ccedil;lara diren&ccedil; mekanizmaları. Mikrobiyol Bul. 2021;55(1):99-112. doi:10.5578/mb.20217
14. Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers. 2018; 4(1):1-20.
15. Kim MN, Shin JH, Sung H, et al. Candida haemulonii and closely related speciesat 5 university hospital in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis. 2009;48(6):e57-e61. doi:10.1086/597108
16. Piedrahita CT, Cadnum JL, Jencson AL, Shaikh AA, Ghannoum MA, Donskey CJ. Environmental surfaces in healthcare facilities are a potential source for transmission of Candida auris and other Candida species. Infect Control Hosp Epidemiol. 2017;38(9):1107-1109. doi:10. 1017/ice.2017.127
17. Ozalp O, Komec S, Unsel M, Gunduz A, Altuntas Aydin O. Analysis of candidemia cases in a city hospital during the COVID-19 pandemic. Eur Rev Med Pharmacol Sci. 2024;28(6):2558-2568. doi:10.26355/eurrev_202403_35762
18. Castanheira M, Deshpande LM, Rhomberg PR, Carvalhaes CG. Recent increase in Candida auris frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization. Antimicrob Agents Chemother. 2024;68(10):e0057024. doi:10.1128/aac. 00570-24
Article available in :
Volume 4, Issue 3, 2025
Page : 58-61
https://doi.org/10.51271/ANKMJ-0048
Article Information
Received : 25 Mar 2025
Accepted : 24 Nis 2025
Published : 29 Tem 2025
Corresponding Author :

Salih Cesur: Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, University of Health Sciences, Ankara, TURKEY

[email protected]
Citation : Yıldız O, Ersoy M, Karataş S, et al. A case developing Candida auris related candidaemia following multiple drug-resistant Klebsiella pneumoniae meningitis after neurosurgical intervention. Ank Med J. 2025;4(3):58-61.

Read: 146
Download : 111
Cited: 0
_Footer